GLS4

DRUG4 trials

Sponsors

Sunshine Lake Pharma Co., Ltd.

Conditions

Chronic HBV InfectionChronic Hepatitis B

Phase 1

A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects

CompletedNCT03662568

Sunshine Lake Pharma Co., Ltd.Chronic Hepatitis B

Start: 2018-06-26End: 2019-06-10Updated: 2019-10-09

GLS4/RTV and TAF Drug-drug Interaction

CompletedNCT04551261

Sunshine Lake Pharma Co., Ltd.Chronic Hepatitis B

Start: 2021-01-10End: 2021-03-12Updated: 2022-05-26

Phase 2

The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules

CompletedNCT03638076

Sunshine Lake Pharma Co., Ltd.Chronic Hepatitis B

Start: 2017-07-26End: 2018-11-29Updated: 2020-07-23

Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection

CompletedNCT04147208

Sunshine Lake Pharma Co., Ltd.Chronic HBV Infection

Start: 2019-02-28End: 2023-09-14Updated: 2024-06-21

Related Papers

Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trial

Journal of Infection2025-02-212 citations